Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.77+0.03 (+1.09%)
Close on Nov 16, 2026Market cap $23.10MP/E –Yield –
Evaxion A/S enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evaxion A/S's enterprise value was $9.96M on Nov 11, 2026, against $836.60K a year earlier. Over the last 4 years it ranged from -$2.58M to $30.75M, with a median of $10.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.96M | – |
| 2025 | Dec 31, 2025 | -$413.32K | -115.1% |
| 2024 | Dec 31, 2024 | $2.74M | -84.2% |
| 2023 | Dec 29, 2023 | $17.32M | – |
See a number that looks wrong?